Silver Book Fact

Antihypertensive therapy has been associated in clinical trials with a 1/3 reduction in stroke incidence, a 1/4 reduction in myocardical infarctions and a more than 1/2 reduction in heart failure.

Chobanian, Aram, George Bakris, Henry Black, William Cushman, Lee Green, Joseph Izzo, Daniel Jones, Barry Materson, Suzanne Oparil, Jackson Wright, and Edward Roccella. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. Hypertension. 2003; 42(6): 1206-52. https://jamanetwork.com/journals/jama/article-abstract/196589?redirect=true

Reference

Title
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure
Publication
Hypertension
Publication Date
2003
Authors
Chobanian, Aram, George Bakris, Henry Black, William Cushman, Lee Green, Joseph Izzo, Daniel Jones, Barry Materson, Suzanne Oparil, Jackson Wright, and Edward Roccella
Volume & Issue
Volume 42, Issue 6
Pages
1206-52
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Compared to predicted levels in the absence of drug therapy, there were 9% fewer deaths from major cardiovascular disease in 2001 and 38% and 25% fewer hospital discharges for stroke…  
  • If all forms of cardiovascular disease were eliminated, life expectancy would rise by close to 7 years.  
  • Anti-platelet therapy stroke risk reduction
    Anti-platelet therapy after a stroke or TIA reduces the risk of nonfatal ischemic strokes by 28% and fatal strokes by 16%.  
  • Because of the advent of imaging and noninvasive testing, Americans who are asymptomatic are being diagnosed with established cardiovascular disease.  
  • Every additional dollar spent on the overall treatment of stroke has produced health gains valued at $1.55.